Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ding Zhi Huang"'
Autor:
Dan-Yun Ruan, Xiao-Li Wei, Fu-Rong Liu, Xi-Chun Hu, Jian Zhang, Dong-Mei Ji, Ding-Zhi Huang, Yan-Qiu Zhao, Hong-Min Pan, Wang-Jun Liao, Kun-Yu Yang, Nong Xu, Xiao-Xiao Lu, Yu-Ling Chen, Wen Zhang, Hui Zhou, Hong-Yun Zhao, Rui-Hua Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Background There is an unmet clinical need to enhance the response rate and safety of anti-PD-1/PD-L1-based cancer immunotherapy (IO). Herein, we presented the clinical study of IBI318 (LY3434172), a first-in-class bispecific antibody (bsAb)
Externí odkaz:
https://doaj.org/article/a9a7ec4c1b9647f89eb73df41a05bd37
Autor:
Yong-Yin Gao, Ru-Bing Han, Xia Wang, Shao-Hua Ge, Hong-Li Li, Ting Deng, Rui Liu, Ming Bai, Li-Kun Zhou, XinYuan Zhang, Yi Ba, Ding-Zhi Huang
Publikováno v:
Cancer Biology & Medicine, Vol 12, Iss 1, Pp 33-40 (2015)
Objective:The expression of tumor biomarkers may change after chemotherapy. However, whether secreted protein acidic and rich in cysteine (SPARC) expression changes after chemotherapy in gastric cancer (GC) is unclear. This study investigated the inf
Externí odkaz:
https://doaj.org/article/036cc76cb34a40b2bac231aeb31e7f86
Autor:
Kai-Ting Jiang, Ding-Zhi Huang
Publikováno v:
Translational Cancer Research
Background Anticancer treatment-related heart events is a major concern. However, the frequent occurrence time of cardiac death and the association between cardiac-specific mortality (CSM) and various lung lobes among non-elderly non-small cell lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c71a1bfcea33fc19864469aac8e0d22
https://pubmed.ncbi.nlm.nih.gov/35116414
https://pubmed.ncbi.nlm.nih.gov/35116414
Autor:
Xu-Wen, Guan, Fang, Zhao, Jing-Ya, Wang, Hai-Yan, Wang, Shao-Hua, Ge, Xia, Wang, Le, Zhang, Rui, Liu, Yi, Ba, Hong-Li, Li, Ting, Deng, Li-Kun, Zhou, Ming, Bai, Tao, Ning, Hai-Yang, Zhang, Ding-Zhi, Huang
Publikováno v:
American journal of cancer research. 7(9)
Poor prognosis of gastric cancer is related to not only malignancy of gastric cancer cells, but also the tumor microenvironment. Thus drugs, which can inhibit both of them, are urgently needed to be explored. Studies on effect of Proton-pump inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91d43371dda7859a55c11947ad2ec250
https://pubmed.ncbi.nlm.nih.gov/28979813
https://pubmed.ncbi.nlm.nih.gov/28979813
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 13:1425-1430
Cyclin L2 is a novel member of the cyclin family, recently implicated in the regulation of cell cycle progression and/or transcriptional regulation. The present study was undertaken to investigate the effects of overexpression on tumor cell growth an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4ee6ee4ef4ace7d1449faec5beba1c
https://doi.org/10.7314/apjcp.2012.13.4.1425
https://doi.org/10.7314/apjcp.2012.13.4.1425
Publikováno v:
Chinese Medical Journal. 120:905-909
BACKGROUND Uncontrolled cell division is one of the hallmarks of tumor growth. Researches have been focused on numerous molecules involved in this process. Cyclins are critical regulatory proteins of cell cycle progression and/or transcription. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf11e0022110cfbebff8175939521c07
https://doi.org/10.1097/00029330-200705020-00010
https://doi.org/10.1097/00029330-200705020-00010
Autor:
Sheng Yang, Shengyu Zhou, Mei Dong, Xiaohong Han, Yuankai Shi, Peng Liu, Bin Ai, Xiaohui He, Ding-Zhi Huang, Changgong Zhang
Publikováno v:
Chemotherapy. 53:44-50
Background: This study observed and compared the preventive effects of ramosetron and ondansetron on gastrointestinal side effects caused by cisplatin-containing chemotherapy. Methods: Fifty patients with malignant tumors undergoing their first chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41ed032a60c6ac378a656c7f097696c
https://doi.org/10.1159/000098418
https://doi.org/10.1159/000098418
Autor:
Yong-Yin Gao, Ru-Bing Han, Xia Wang, Shao-Hua Ge, Hong-Li Li, Ting Deng, Rui Liu, Ming Bai, Li-Kun Zhou, XinYuan Zhang, Yi Ba, Ding-Zhi Huang
Publikováno v:
Cancer Biology & Medicine
Cancer Biology & Medicine, Vol 12, Iss 1, Pp 33-40 (2015)
Cancer Biology & Medicine, Vol 12, Iss 1, Pp 33-40 (2015)
Objective:The expression of tumor biomarkers may change after chemotherapy. However, whether secreted protein acidic and rich in cysteine (SPARC) expression changes after chemotherapy in gastric cancer (GC) is unclear. This study investigated the inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f2e4455200d726981c59ca80062c5a58
https://pubmed.ncbi.nlm.nih.gov/25859409
https://pubmed.ncbi.nlm.nih.gov/25859409
Autor:
Nong Xu, Jian Ping Xiong, Ding Zhi Huang, Yang Zhang, Zhuang Yu, Yi Ba, Zhong He Yu, Ting Deng, Zeng Qing Guo, Rong Sheng Zheng, Mei Ling Wang, Chun Hong Hu, Yang Yao, Zhao Yan, Zhi Xiang Zhuang, Hui Ping Wan, Ji Chang Meng
Publikováno v:
Journal of chemotherapy (Florence, Italy). 25(1)
To report the results of a safety analysis from a phase II trial comparing administration of weekly paclitaxel plus S-1 (TS) versus paclitaxel plus 5-fluorouracil (5-FU)/calcium folinate (LV) (TLF) as first-line therapy for advanced gastric cancer.Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feaf055f9636e7c1d5283fa235741d97
https://pubmed.ncbi.nlm.nih.gov/23433446
https://pubmed.ncbi.nlm.nih.gov/23433446
Autor:
Ding-zhi, Huang, Jian-ping, Xiong, Nong, Xu, Zhao, Yan, Zhi-xiang, Zhuang, Zhuang, Yu, Hui-ping, Wan, Yang, Zhang, Ting, Deng, Rong-sheng, Zheng, Zeng-qing, Guo, Chun-hong, Hu, Mei-Ling, Wang, Zhong-He, Yu, Yang, Yao, Ji-chang, Meng, Yi, Ba
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 34(11)
To evaluate the efficacy and safety of weekly paclitaxel combined with S-1 or fluorouracil in the first line treatment of advanced gastric carcinoma.Two hundred and forty patients with untreated advanced gastric carcinoma were randomized into two arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::774364e4771351dc76fec01566ae3da6
https://pubmed.ncbi.nlm.nih.gov/23291139
https://pubmed.ncbi.nlm.nih.gov/23291139